BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12526923)

  • 1. Fc epsilon RI and CD22 mRNA are expressed in early B-lineage and myeloid leukemia cell lines.
    Toba K; Hanawa H; Sakaue M; Yoshida K; Itoh H; Tsuchiyama J; Maruyama S; Narita M; Takahashi M; Watanabe K; Aizawa Y
    Leuk Res; 2003 Feb; 27(2):173-82. PubMed ID: 12526923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human basophils express CD22 without expression of CD19.
    Han K; Kim Y; Lee J; Lim J; Lee KY; Kang CS; Kim WI; Kim BK; Shim SI; Kim SM
    Cytometry; 1999 Nov; 37(3):178-83. PubMed ID: 10520197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous expression of CD13, CD22 and CD25 is related to the expression of Fc epsilon R1 in non-lymphoid leukemia.
    Sato N; Kishi K; Toba K; Watanabe K; Itoh H; Narita M; Takahashi M; Aizawa Y
    Leuk Res; 2004 Jul; 28(7):691-8. PubMed ID: 15158090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in CD22 molecules in human B cells and basophils.
    Toba K; Hanawa H; Fuse I; Sakaue M; Watanabe K; Uesugi Y; Higuchi W; Takahashi M; Aizawa Y
    Exp Hematol; 2002 Mar; 30(3):205-11. PubMed ID: 11882357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of cytoplasmic antigens by flow cytometry and its implication for leukemia immunophenotyping].
    Liu YR; Yu H; Chang Y; Chen SS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):17-21. PubMed ID: 12513830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion.
    Schwartz-Albiez R; Dörken B; Monner DA; Moldenhauer G
    Int Immunol; 1991 Jul; 3(7):623-33. PubMed ID: 1716973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute trilineage leukemia with monosomy of chromosome 7 following an acute promyelocytic leukemia.
    Felice MS; Rossi J; Gallego M; Zubizarreta PA; Cygler AM; Alfaro E; Sackmann-Muriel F
    Leuk Lymphoma; 1999 Jul; 34(3-4):409-13. PubMed ID: 10439380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and structure of CD22 in acute leukemia.
    Boué DR; LeBien TW
    Blood; 1988 May; 71(5):1480-6. PubMed ID: 3258772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric detection of cytoplasmic antigens in acute leukemias: implications for lineage assignment.
    Drach D; Drach J; Glassl H; Gattringer C; Huber H
    Leuk Res; 1993 May; 17(5):455-61. PubMed ID: 8388970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule.
    Torres RM; Law CL; Santos-Argumedo L; Kirkham PA; Grabstein K; Parkhouse RM; Clark EA
    J Immunol; 1992 Oct; 149(8):2641-9. PubMed ID: 1401903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD22 on the human basophils bind differently to anti-CD22 of different manufacturers.
    Han K; Kim Y; Lee S; Kang CS
    Cytometry; 2000 Jul; 40(3):251. PubMed ID: 10878569
    [No Abstract]   [Full Text] [Related]  

  • 14. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
    Razi N; Varki A
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides.
    Rani S; De Oliveira MS; Catovsky D
    Hematol Pathol; 1988; 2(2):73-8. PubMed ID: 2974027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.
    Batata A; Shen B
    Cancer; 1992 Nov; 70(10):2436-43. PubMed ID: 1384948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD19 signaling pathways play a major role for murine AIDS induction and progression.
    Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
    J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression.
    Rudge EU; Cutler AJ; Pritchard NR; Smith KG
    J Exp Med; 2002 Apr; 195(8):1079-85. PubMed ID: 11956299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia.
    Sartor M; Bradstock K
    Cytometry; 1994 Sep; 18(3):119-22. PubMed ID: 7813331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background.
    Poe JC; Haas KM; Uchida J; Lee Y; Fujimoto M; Tedder TF
    J Immunol; 2004 Feb; 172(4):2100-10. PubMed ID: 14764675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.